All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Phthalates are widely used in many daily products such as di-2-ethylhexyl phthalate (DEHP) in plastics, toys and medical equipment; diethyl phthalates (DEP) in cosmetics and personal care products; and di-*n*-butyl phthalate (DnBP) in food package film and plastic products ([S1 Table](#pone.0133782.s001){ref-type="supplementary-material"}). Humans may be exposed to phthalates mainly through ingestion of phthalate-tainted food, or inhalation and dermal absorption of phthalate-contained products; urinary metabolites are considered to be good biomarkers for assessing their exposure \[[@pone.0133782.ref001]--[@pone.0133782.ref002]\]. In 2011, the Taiwan Food and Drug Administration discovered illegal-use of phthalates, such as DEHP, DnBP and di-i-butyl phthalate (DiBP) in beverage, food and nutrition supplements \[[@pone.0133782.ref003]--[@pone.0133782.ref004]\]. Although most contaminant products were removed and immediate regulatory action occurred, human phthalate exposure monitoring remains necessary to evaluate actual phthalate exposure levels and their potential risk in the Taiwanese population.

Growing evidence has indicated some endocrine-related effects of phthalates on human health \[[@pone.0133782.ref005]\], especially in the thyroid and reproductive glands \[[@pone.0133782.ref006]\]. Some studies have revealed that phthalates may decrease thyroid and growth hormones in different races \[[@pone.0133782.ref007]--[@pone.0133782.ref010]\]. Other studies have revealed concerns related to phthalate exposure effects on pediatric allergy diseases \[[@pone.0133782.ref011]--[@pone.0133782.ref012]\] and adult infertility \[[@pone.0133782.ref013]--[@pone.0133782.ref015]\]. Some studies have indicated that several factors, such as age, gender, or lifestyle, may affect the exposure levels of phthalates \[[@pone.0133782.ref016]--[@pone.0133782.ref018]\] and influence their effects on the health of different populations.

A well-organized human biomonitoring study is useful for determining the exposure dose in the general population and assessing exposure, risk, and management of complications \[[@pone.0133782.ref019]\]. Some studies, including the German Environmental Survey (GerEs) \[[@pone.0133782.ref019]\] and National Health and Nutrition Survey (NHANES) \[[@pone.0133782.ref002]\], have demonstrated the time-trend variation and potential influence of environmental chemicals in the general population. Recent studies, such as the Canadian Health Measures Survey (CHMS) \[[@pone.0133782.ref020]\], Korean Environmental Health Survey (KEHS) \[[@pone.0133782.ref021]\], Consortium to Perform Human Biomonitoring on a European Scale (COPHES) and DEMOCOPHES study \[[@pone.0133782.ref022]\], Belgium (FLEHS) \[[@pone.0133782.ref023]\] and Danish studies \[[@pone.0133782.ref024]\], have revealed exposure profiles of populations affected by environmental chemicals differ according to countries, lifestyles, and exposure sources. We aimed to conduct an exposure assessment study of phthalates, a part of the Taiwan Environmental Surveys for Toxicants (TESTs), using biosamples from a general population in Taiwan and evaluating the effects of relevant factors such as demographic characteristics and lifestyle on phthalate exposure.

Materials and Methods {#sec006}
=====================

Ethics statement {#sec007}
----------------

This study was approved by Research Ethics Committee, National Health Research Institutes (No. EC1020206) in Taiwan. Written informed consent from each participant and additional signatures from their parents for minors was obtained prior to study enrollment.

Subject recruitment and data collection {#sec008}
---------------------------------------

In order to obtain sufficient participation from the general Taiwanese population, we collaborated with the National and Nutrition Health Survey in Taiwan (NAHSIT) team and used the same sampling frame and procedure in subject recruitment \[[@pone.0133782.ref025]\]. There are five major regions and 22 cities/ counties in Taiwan ([Fig 1](#pone.0133782.g001){ref-type="fig"}). Briefly, NAHSIT selected twenty major cities/ counties of Taiwan and selected subjects in all age groups. According to the population density and urbanization of each city in Taiwan, each city township is classified into two groups. Then, NAHSIT randomly selected two townships of each group to represent a city/ county. Subjects had to be Taiwanese ≥7 years old, and excluded pregnant and breast-feeding women, individuals with severe disease (e.g. cancer patients), foreigners, and citizens in hospitals and jails \[[@pone.0133782.ref025]\]. We selected seventeen townships of eleven cities/ counties in the northern region (ex.: Taipei and New Taipei City), central region (ex.: Taichung and Chia-Yi City), southern region (ex.: Kaohsiung City), eastern region (ex.: Hua-Lien County), and the remote island region (Peng-Hu County) of Taiwan ([Fig 1](#pone.0133782.g001){ref-type="fig"}) during a time period from May to December 2013. We interviewed a total of 500 subjects on the day of health examination at community center or elementary school; 394 subjects participated in this study, which yielded a response rate around 78%. Most of the subjects who refused participation were children afraid to provide samples.

![Eleven sampling sites of the TEST study in Taiwan.](pone.0133782.g001){#pone.0133782.g001}

After informed consent was obtained, first morning urine samples (20 mL) were collected using a PP container and transferred into an acetonitrile (ACN)-prewashed amber glass bottle and stored at -20 ℃. An interview questionnaire was also used to obtain information about participant demographics (age, gender, residence, education), environmental exposure (cigarette smoking, pesticide usage), lifestyles (plastics product usage, personal care products), and other related factors (disease history).

Phthalate metabolite analysis {#sec009}
-----------------------------

Eleven phthalate metabolites including mono-ethylhexyl phthalate (MEHP), mono-(2-ethyl-5-oxo-hexyl) phthalate (MEOHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono-(2-carboxymethylhexyl) phthalate (MCMHP), mono-*n*-butyl phthalate (MnBP), mono-iso-butyl phthalate (MiBP), mono-ethyl phthalate (MEP), mono-iso-nonyl phthalate (MiNP), mono-benzyl phthalate (MBzP) and mono-methyl phthalate (MMP) representing exposure to seven commonly used phthalates (DEHP, DnBP, DiBP, DEP, di-iso-nonyl phthalate (DiNP), benzyl butyl phthalates (BBzP) and dimethyl phthalate (DMP) were measured in each urine sample. We used a modified method previously described by Koch et al. \[[@pone.0133782.ref026]\] using on-line chromatography to increase the efficiency and accuracy of analysis. After a urine sample was thawed and sonicated for 10--15 min, the urine sample (100 μl) was loaded into a glass vial (2 ml) which contained ammonium acetate (AA, 20 μl, \>98%, Sigma Aldrich Lab., Inc., St. Louis, MO, USA), β-glucuronidase (10 μl, E.coli K12, Roche Biomedical, Mannheim, Germany), and a mixture of ten isotopic (^13^C~4~) phthalate metabolite standards (100 μl. Cambridge Isotope Lab., Inc., Andover, MA, USA). After the sample was incubated (37℃, 90 min), a 270 μl solution (5% ACN), Merck, Darmstadt, Germany) with 0.1% formic acid (FA, Merck, Darmstadt, Germany) was added and sealed with the PTEF cap for analysis. We used an on-line system which was coupled with liquid chromatography/electrospray tandem mass spectrometry (LC--ESI-MS/MS) (Agilent 1200/ API 4000, Applied Biosystems, Foster City, CA, USA). We used two columns in our on-line system. One C18 column (Inertsil ODS-3, 33×4.6 mm, 5 μm, GL Science, Tokyo, Japan) was used to extract and clean our sample, and an analytical column (Inertsil Ph, 150 \*4.6 mm, 5 μm, GL Science, Tokyo, Japan) was used to separate different phthalate metabolites. The gradient program of the clean-up column was listed as follows: 100% solution A (5% ACN + 0.1% FA) (0--7 min), 100% solution B (90% ACN + 0.1% FA) (7--9 min), 100% solution A (9--10 min) and continued to 12 min. The flow rate was set at 1000 μl/min. The analytical column gradient program was listed as follows: 100% solution C (50% ACN + 10 mmole AA) (0--3.6 min), 100% solution D (95% ACN + 10 mmole AA) (3.6--8.6 min), 100% solution C (8.6--9 min) and continued to 12 min. We used a negative multiple reaction monitoring model for mass spectroscopy detection. The ion pair of each phthalate metabolites was listed as follows: MEHP (277/134), MEOHP (291/143), MEHHP (293/121), MECPP (307/159), MCMHP (307/113), MnBP (221/71), MiBP (221/71), MEP (193/121), MiNP (291/121), MBzP (255/183), and MMP (179/107). The detection limits of MEHP, MEOHP, MEHHP, MECPP, MCMHP, MnBP, MiBP, MEP, MiNP, MBzP, and MMP were 0.7, 0.3, 0.3, 0.3, 0.1, 1, 1, 0.3, 0.1, 0.3 and 0.3 ng/mL respectively. One blank, repeat, and quality control (QC) sample were included in each batch of analyzed samples. The concentration of blank samples shall be below two times the detection limit. The QC sample was spiked in a pooled urine sample with a mixture of phthalate metabolite standards (20--50 ng/ml) in each sample. The relative percent difference of repeat sample and recovery of QC sample shall be within ± 30%. Urinary creatinine levels were measured by spectrophotometric methods, with picric acid as a reactive compound for reading at 520 nm measurement (Beckman; DXC 800).

Statistical Analysis {#sec010}
--------------------

Levels of urinary phthalate metabolites and creatinine were evaluated as continuous variables. Meanwhile, age, gender, residence, education, family income, cigarette smoking and beverage status (tea, coffee, alcohol), as well as the frequency of plastic products, personal care products, and pesticide use were evaluated as nominal variables. All measured phthalate metabolites were logarithmically (log~10~) transformed for Pearson correlation analysis. We categorized our subjects into adults (≧18 years old) and minors (\<18 years old), and further stratified four comparatively sized age groups: ≧7\~\<18 years old, ≧18\~\<40 years old, ≧40\~\<65 years old, ≧65 years old (elders). The Mann-Whitney U test, Chi-square test, and Kruskal-Wallis test were used to evaluate differences between demographic data, such as age and gender, region, and each level of phthalate metabolites for continuous and categorical variables, respectively. We calculated not detectable (ND) levels, below the detection limit, as 1/2 detection limit of each phthalate metabolite, and detectable rate as number of urine sample with level of each phthalate metabolite above detection limit divided by all analyzed urine samples. We presented our data both in a creatinine-based level, which adjusted for individual urinary excretion rate, and creatinine-unadjusted level in the parentheses. Pearson correlation coefficients assessed correlations between age and each urinary phthalate metabolite level. Commercially available statistical software (SPSS version 22.0; SAS Institute, Cary, NC, USA) was used for all statistical analysis. The level of significance was set at *P*\< 0.05.

Results {#sec011}
=======

Characteristics of Subjects {#sec012}
---------------------------

A total of 296 adults and 98 minors with completed data were included for statistical analysis in this study. In adults, most participants were between 40--65 years of age (44%), married (72.9%), well-educated (56.8%), middle-class status (57%), non-smokers (74.3%), and reported no pesticide use at home (74.7%); around half were tea and coffee drinkers (57.4% and 42.9%, respectively). A high percentage of participants did not drink alcohol (85.8%) or chew betel nuts (93.2%). For minors, around half of them were boys (55%), below 12 years old (52%); half of them reported as tea drinkers and passive smokers. The detailed demographic characteristics of all participants were shown in [Table 1](#pone.0133782.t001){ref-type="table"}.

10.1371/journal.pone.0133782.t001

###### Demographic characteristics of all participants in this study (N = 394).

![](pone.0133782.t001){#pone.0133782.t001g}

  Characteristics                                               Item                 Adults (≧18 years, n = 296)   Minors (\<18 years, n = 98)            
  ------------------------------------------------------------- -------------------- ----------------------------- ----------------------------- -------- ------------
  Gender                                                        Male                 136                           45.9                          54       55.1
  Female                                                        160                  54.1                          44                            44.9     
  Age (years)                                                   18--40/ 7--12        71                            24.0                          51       52.0
  40--65/ 12--18                                                131                  44.2                          47                            48.0     
  65 and older                                                  94                   31.8                          0                             0        
  Region                                                        Northern Taiwan      90                            30.4                          31       31.6
  Central Taiwan                                                39                   13.2                          15                            15.3     
  Southern Taiwan                                               82                   27.7                          24                            24.5     
  Eastern Taiwan                                                56                   18.9                          12                            12.2     
  Remote island                                                 29                   9.8                           16                            16.4     
  Marriage status                                               Single               49                            16.6                          97       99.0
  Married                                                       216                  72.9                          1                             1.0      
  Divorce/ widowed                                              31                   10.5                          0                             0        
  Education                                                     ≦Elementary school   84                            28.3                          51       52.0
  Junior high school                                            44                   14.9                          29                            29.6     
  Senior high school                                            68                   23.0                          18                            18.4     
  ≧College/ Graduates                                           100                  33.8                          0                             0        
  Annual family income [^a^](#t001fn001){ref-type="table-fn"}   \<15,625             169                           59.5                          39       43.3
  15,625\~31,250                                                74                   26.1                          30                            33.3     
  \>31,250                                                      41                   14.4                          21                            23.4     
  Cigarette smoking [^b^](#t001fn002){ref-type="table-fn"}      Yes/ No              75/ 220                       25.4/ 74.6                    2/ 96    2.0/ 98.0
  Passive smoker                                                Yes/ No              148/ 147                      50.2/ 49.8                    50/ 47   51.4/ 48.6
  Alcohol consumption [^c^](#t001fn003){ref-type="table-fn"}    Yes/ No              36/ 255                       12.4/ 87.6                    1/ 96    1.0/ 99.0
  Tea drinking [^d^](#t001fn004){ref-type="table-fn"}           Yes/ No              171/ 124                      58.0/ 42.0                    49/ 49   50.0/ 50.0
  Coffee drinking [^d^](#t001fn004){ref-type="table-fn"}        Yes/ No              127/ 169                      42.9/ 57.1                    6/ 92    6.1/ 93.9
  Betel nut chewing [^e^](#t001fn005){ref-type="table-fn"}      Yes/ No              20/ 276                       6.8/ 93.2                     1/ 97    1.0/ 99.0
  Pesticide use at home                                         Yes/ No              75/ 221                       25.3/ 74.7                    28/ 70   28.6/ 71.4

^a^ The currency exchange rate of converting USD to new Taiwan dollar is 1:32.

^b^ Subjects who self-reported consuming at least one cigarette per day.

^c^ Subject who self-reported consuming at least one bottle of alcohol drink per week.

^d^ Subjects who self-reported consuming at least one cup of tea or coffee per week.

^e^ Subject who self-reported chewing at least one betel nut per week.

Levels of eleven phthalate metabolites {#sec013}
--------------------------------------

[Fig 2](#pone.0133782.g002){ref-type="fig"} and [Table 2](#pone.0133782.t002){ref-type="table"} (un-adjusted data was shown in the parentheses of [Table 2](#pone.0133782.t002){ref-type="table"}) showed the distribution and creatinine-adjusted concentrations of eleven phthalate metabolites in our participants classified by age and gender, respectively. For adults, the median levels of MEHHP (women/ men: 24.1 vs. 18.3 μg/g-c, *P* = 0.011), MECPP (28.3 vs. 24.4 μg/g-c, *P* = 0.010), MnBP (22.1 vs. 13.8 μg/g-c, *P* = 0.001), MEP (19.6 vs. 10.4 μg/g creatinine \[μg/g-c\], *P*\<0.001), MBzP (0.3 vs. 0.2 μg/g-c, *P\<*0.001), MiNP (0.3 vs. 0.2 μg/g-c, *P\<*0.001) in women (≧18 year old, n = 156) were significantly higher than those seen in men (≧18 year old, n = 134). For minors, the median levels of most phthalate metabolites in boys (n = 54) was higher than those in girls (n = 43), but no statistical significance was observed. We found that the median levels of MEOHP, MEHHP, MECPP, MnBP, MiBP and MMP in minors were higher than those seen in adults.

10.1371/journal.pone.0133782.t002

###### Distribution of creatinine-adjusted levels (μg/g creatinine or ng/ml) of phthalate metabolites [^a^](#t002fn001){ref-type="table-fn"} in a sample of the general Taiwanese population (N = 387) by minors and adults.

![](pone.0133782.t002){#pone.0133782.t002g}

  Phthalate metabolites   Group          Detectable rate (%)   n      GM       Min      5th     25th   50th    75th    95th     Max      *P*-value [^b^](#t002fn002){ref-type="table-fn"}                                                                                  
  ----------------------- -------------- --------------------- ------ -------- -------- ------- ------ ------- ------- -------- -------- -------------------------------------------------- -------- -------- -------- --------- --------- ---------- ---------- --------- -----------
  MEHP                    ***Adults***   76.4                  290    4.4      (3.4)    ND      (ND)   ND      (ND)    2.4      (2.1)    7.9                                                (6.6)    15.5     (12.2)   34.9      (30.5)    110.3      (138.9)    0.211     (0.556)
   Men                    75.7           134                   4.0    (3.6)    ND       (ND)    ND     (ND)    1.9     (1.6)    7.7      (7.1)                                              15.0     (13.9)   31.9     (37.7)    51.0      (62.9)     0.414      (0.215)   
   Women                  76.9           156                   4.8    (3.3)    ND       (ND)    ND     (ND)    3.9     (2.5)    8.0      (6.1)                                              15.9     (11.3)   40.7     (28.6)    110.3     (138.9)                         
  ***Minors***            80.6           97                    4.0    (4.1)    ND       (ND)    ND     (ND)    2.4     (3.1)    6.1      (7.2)                                              12.5     (12.2)   27.2     (27.5)    74.3      (69.1)                          
   Boys                   88.9           54                    5.2    (6.3)    ND       (ND)    ND     (ND)    3.2     (4.6)    6.6      (8.6)                                              13.8     (15.7)   27.3     (36.5)    74.3      (69.1)     0.196      (0.009)   
   Girls                  70.5           43                    2.8    (2.4)    ND       (ND)    ND     (ND)    ND      (ND)     5.3      (5.9)                                              11.2     (8.7)    30.0     (24.8)    37.2      (27.1)     　                   
  MEOHP                   ***Adults***   93.2                  290    10.7     (8.3)    ND      (ND)   ND      (ND)    8.2      (5.6)    12.6                                               (10.3)   20.2     (16.5)   38.2      (33.7)    244.5      (289.6)    \<0.001   (\<0.001)
   Men                    94.1           134                   10.0   (9.1)    ND       (ND)    ND     (ND)    7.5     (5.9)    12.0     (11.5)                                             18.3     (18.5)   29.7     (35.9)    146.5     (178.8)    0.091      (0.115)   
   Women                  92.5           156                   11.3   (7.6)    ND       (ND)    ND     (ND)    8.4     (5.5)    13.6     (9.6)                                              21.6     (14.9)   43.6     (33.9)    244.5     (289.6)                         
  ***Minors***            99.0           97                    16.9   (17.2)   ND       (ND)    4.3    (4.2)   9.6     (9.7)    17.8     (19.1)                                             29.1     (31.3)   61.5     (80.7)    140.2     (150.0)                         
   Boys                   100            54                    19.3   (23.0)   3.4      (3.5)   5.1    (5.2)   11.3    (15.0)   19.8     (24.4)                                             36.3     (33.6)   68.7     (108.5)   140.2     (150.0)    0.159      (0.001)   
   Girls                  97.7           43                    14.2   (11.9)   ND       (ND)    4.2    (2.5)   8.7     (6.6)    16.2     (15.1)                                             25.4     (21.1)   54.9     (59.4)    72.8      (68.9)                          
  MEHHP                   ***Adults***   98.0                  290    20.2     (15.6)   ND      (ND)   6.3     (4.1)   13.4     (9.8)    22.0                                               (16.3)   32.6     (30.0)   73.6      (69.0)    415.7      (487.7)    0.116     (\<0.001)
   Men                    96.3           134                   16.8   (15.3)   ND       (ND)    4.7    (3.1)   11.6    (8.9)    18.3     (18.2)                                             29.3     (31.5)   58.2     (75.3)    266.7     (325.4)    0.011      (0.425)   
   Women                  99.4           156                   23.6   (15.9)   ND       (ND)    7.3    (4.8)   14.7    (9.9)    24.1     (15.1)                                             33.7     (25.7)   87.6     (61.8)    415.7     (487.7)                         
  ***Minors***            96.9           97                    21.9   (22.3)   ND       (ND)    6.2    (6.4)   14.9    (14.6)   25.8     (25.1)                                             43.9     (38.7)   84.7     (104.4)   134.7     (245.9)                         
   Boys                   98.1           54                    25.0   (29.8)   ND       (ND)    6.2    (6.7)   14.8    (19.3)   26.8     (29.2)                                             50.3     (57.3)   89.0     (162.1)   134.7     (245.9)    0.153      (0.002)   
   Girls                  95.5           43                    18.5   (15.5)   ND       (ND)    1.8    (0.8)   14.8    (10.0)   19.1     (20.0)                                             37.6     (28.3)   69.9     (64.0)    101.3     (91.0)     　                   
  MECPP                   ***Adults***   95.9                  290    22.3     (17.2)   ND      (ND)   6.6     (2.7)   16.4     (10.9)   25.4                                               (20.3)   39.4     (32.1)   101.4     (88.7)    654.4      (975.1)    0.016     (\<0.001)
   Men                    94.9           134                   18.4   (16.7)   ND       (ND)    ND     (ND)    14.2    (10.0)   24.4     (22.1)                                             34.9     (32.7)   88.3     (87.1)    434.2     (529.7)    0.010      (0.759)   
   Women                  96.9           156                   26.3   (17.7)   ND       (ND)    7.9    (3.7)   17.2    (11.5)   28.3     (19.6)                                             47.2     (30.5)   112.3    (98.0)    654.4     (975.1)                         
  ***Minors***            96.9           97                    28.3   (28.9)   ND       (ND)    8.1    (5.5)   19.0    (19.0)   30.8     (34.6)                                             56.2     (56.0)   109.1    (123.7)   150.6     (339.0)                         
   Boys                   98.1           54                    32.1   (38.2)   ND       (ND)    7.9    (9.5)   19.4    (23.5)   32.4     (37.9)                                             62.9     (71.6)   118.2    (159.0)   150.6     (339.0)    0.257      (0.001)   
   Girls                  95.5           43                    24.2   (20.4)   ND       (ND)    2.0    (1.3)   16.9    (15.4)   30.6     (26.1)                                             47.2     (37.8)   94.6     (82.1)    135.3     (166.4)    　                   
  MCMHP                   ***Adults***   64.9                  290    2.0      (1.6)    ND      (ND)   ND      (ND)    ND       (ND)     4.1                                                (3.2)    7.7      (6.6)    16.1      (14.6)    167.0      (203.7)    0.067     (0.001)
   Men                    66.2           134                   2.0    (1.8)    ND       (ND)    ND     (ND)    ND      (ND)     3.9      (3.8)                                              7.4      (8.0)    14.6     (15.6)    167.0     (203.7)    0.598      (0.085)   
   Women                  63.8           156                   2.1    (1.4)    ND       (ND)    ND     (ND)    ND      (ND)     4.2      (2.9)                                              8.0      (5.6)    20.5     (13.5)    115.1     (171.4)                         
  ***Minors***            75.5           97                    2.9    (2.9)    ND       (ND)    ND     (ND)    0.9     (1.2)    4.6      (5.6)                                              10.9     (10.1)   18.7     (24.5)    37.5      (46.2)                          
   Boys                   81.5           54                    3.4    (4.1)    ND       (ND)    ND     (ND)    2.0     (3.1)    6.0      (6.3)                                              11.7     (11.8)   18.6     (31.9)    24.0      (41.1)     0.244      (0.015)   
   Girls                  68.2           43                    2.3    (1.9)    ND       (ND)    ND     (ND)    ND      (ND)     4.4      (3.9)                                              9.9      (7.8)    28.8     (22.8)    37.5      (46.2)     　                   
  MnBP                    ***Adults***   87.2                  290    12.8     (9.9)    ND      (ND)   ND      (ND)    8.8      (6.0)    18.1                                               (15.8)   31.4     (28.9)   142.6     (87.4)    5088.2     (6105.8)   0.021     (\<0.001)
   Men                    87.5           134                   10.6   (9.6)    ND       (ND)    ND     (ND)    7.1     (5.5)    13.8     (14.6)                                             25.5     (28.2)   135.6    (83.9)    5088.2    (6105.8)   0.001      (0.417)   
   Women                  86.9           156                   15.1   (10.2)   ND       (ND)    ND     (ND)    10.7    (7.3)    22.1     (16.9)                                             40.1     (29.9)   152.9    (118.4)   1780.2    (836.7)                         
  ***Minors***            92.9           97                    17.6   (18.0)   ND       (ND)    ND     (ND)    11.2    (13.8)   23.6     (21.7)                                             40.6     (43.5)   109.2    (125.8)   194.0     (158.2)                         
   Boys                   88.9           54                    16.4   (19.5)   ND       (ND)    ND     (ND)    10.9    (15.1)   25.1     (29.4)                                             53.6     (61.3)   146.2    (139.6)   194.0     (158.2)    0.416      (0.016)   
   Girls                  97.7           43                    19.3   (16.2)   ND       (ND)    5.7    (3.0)   13.3    (12.9)   21.0     (16.0)                                             33.1     (32.0)   76.8     (58.5)    108.0     (78.6)     　                   
  MiBP                    ***Adults***   70.9                  290    4.4      (3.4)    ND      (ND)   ND      (ND)    ND       (ND)     9.4                                                (7.0)    19.1     (17.2)   68.4      (47.4)    129.7      (286.6)    0.032     (\<0.001)
   Men                    70.6           134                   3.7    (3.4)    ND       (ND)    ND     (ND)    ND      (ND)     7.4      (6.6)                                              17.9     (16.6)   54.5     (59.4)    129.7     (286.6)    0.069      (0.811)   
   Women                  71.3           156                   5.1    (3.4)    ND       (ND)    ND     (ND)    ND      (ND)     11.2     (7.5)                                              23.2     (17.9)   93.1     (38.8)    115.0     (141.7)                         
  ***Minors***            80.6           97                    7.2    (7.3)    ND       (ND)    ND     (ND)    4.7     (4.9)    13.6     (15.3)                                             24.2     (29.3)   76.4     (75.0)    138.0     (200.1)                         
   Boys                   83.3           54                    7.8    (9.3)    ND       (ND)    ND     (ND)    6.1     (6.6)    15.0     (18.2)                                             23.6     (29.7)   72.7     (78.3)    138.0     (200.1)    0.632      (0.109)   
   Girls                  77.3           43                    6.4    (5.4)    ND       (ND)    ND     (ND)    3.0     (2.1)    10.4     (10.3)                                             27.7     (29.2)   80.7     (79.3)    100.0     (83.3)     　                   
  MEP                     ***Adults***   91.2                  290    14.0     (10.8)   ND      (ND)   ND      (ND)    6.7      (5.1)    14.5                                               (12.2)   33.7     (29.2)   173.8     (199.2)   4675.1     (3286.0)   0.267     (0.479)
   Men                    90.4           134                   9.9    (9.0)    ND       (ND)    ND     (ND)    4.6     (4.0)    10.4     (9.6)                                              27.4     (27.9)   145.9    (196.6)   2376.0    (3286.0)   \<0.001    (0.055)   
   Women                  91.9           156                   18.7   (12.6)   ND       (ND)    ND     (ND)    9.4     (6.0)    19.6     (13.9)                                             44.2     (30.0)   204.3    (210.2)   4675.1    (2571.3)                        
  ***Minors***            92.9           97                    11.5   (11.7)   ND       (ND)    ND     (ND)    6.5     (5.5)    12.4     (14.2)                                             25.3     (29.6)   80.8     (151.3)   412.0     (626.4)                         
   Boys                   96.3           54                    12.9   (15.3)   ND       (ND)    1.3    (1.8)   8.2     (9.3)    13.0     (17.9)                                             24.8     (33.2)   72.8     (155.9)   248.6     (392.3)    0.468      (0.063)   
   Girls                  88.6           43                    10.0   (8.4)    ND       (ND)    ND     (ND)    5.0     (3.5)    11.1     (9.7)                                              26.9     (27.0)   222.3    (204.5)   412.0     (626.4)    　                   
  MiNP                    ***Adults***   12.8                  290    ND       (ND)     ND      (ND)   ND      (ND)    ND       (ND)     ND                                                 (ND)     ND       (ND)     4.0       (3.5)     39.7       (15.0)     0.005     (0.776)
   Men                    9.6            134                   ND     (ND)     ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     3.2      (3.5)     12.1      (15.0)     \<0.001    (0.184)   
   Women                  15.6           156                   ND     (ND)     ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     5.4      (3.6)     39.7      (11.1)                          
  ***Minors***            12.2           97                    ND     (ND)     ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     9.1      (8.1)     43.4      (49.5)                          
   Boys                   13.0           54                    0.2    (0.3)    ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     10.2     (12.1)    43.4      (49.5)     0.045      (0.584)   
   Girls                  11.4           43                    ND     (ND)     ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     13.2     (9.9)     16.9      (22.2)     　                   
  MBzP                    ***Adults***   22.3                  290    0.4      (0.3)    ND      (ND)   ND      (ND)    ND       (ND)     ND                                                 (ND)     ND       (ND)     7.8       (5.6)     75.9       (15.7)     0.403     (0.144)
   Men                    22.1           134                   0.3    (0.3)    ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     5.4      (5.9)     16.7      (12.8)     0.011      (0.837)   
   Women                  22.5           156                   0.4    (0.3)    ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               ND       (ND)     8.4      (5.2)     75.9      (15.7)                          
  ***Minors***            28.6           97                    0.4    (0.4)    ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               1.7      (2.1)    7.5      (12.4)    12.7      (27.1)                          
   Boys                   38.9           54                    0.5    (0.6)    ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               3.0      (3.0)    11.1     (15.2)    12.7      (27.1)     0.547      (0.007)   
   Girls                  15.9           43                    ND     (ND)     ND       (ND)    ND     (ND)    ND      (ND)     ND       (ND)                                               0.3      (0.2)    6.4      (5.2)     10.2      (18.3)     　                   
  MMP                     ***Adults***   96.6                  290    31.3     (24.2)   ND      (ND)   4.6     (3.8)   15.5     (10.8)   30.9                                               (23.9)   66.5     (54.3)   308.4     (282.8)   6529.6     (7117.3)   0.094     (0.001)
   Men                    97.1           134                   29.4   (26.7)   ND       (ND)    3.9    (3.4)   14.7    (12.7)   27.4     (26.1)                                             59.3     (52.8)   376.5    (324.6)   993.9     (1350.3)   0.339      (0.182)   
   Women                  96.3           156                   33.0   (22.2)   ND       (ND)    6.1    (3.6)   15.9    (9.7)    32.6     (22.3)                                             70.5     (57.3)   285.7    (258.9)   6529.6    (7117.3)                        
  ***Minors***            98.0           97                    37.5   (38.2)   ND       (ND)    5.1    (4.8)   21.2    (18.1)   41.2     (43.0)                                             79.0     (83.3)   215.7    (381.8)   1355.1    (1004.9)                        
   Boys                   100            54                    37.4   (44.5)   4.5      (4.5)   5.2    (8.2)   20.9    (22.9)   41.6     (45.9)                                             70.4     (83.7)   138.5    (392.7)   159.0     (456.4)    0.965      (0.345)   
   Girls                  95.5           43                    37.5   (31.5)   ND       (ND)    1.3    (0.7)   21.2    (11.5)   39.3     (40.0)                                             81.1     (82.3)   1088.8   (667.6)   1355.1    (1004.9)   　                   

^a^ Abbreviations: MBzP: mono-benzyl phthalate; MiBP: mono-iso-butyl phthalate; MnBP: mono-*n*-butyl phthalate, MCMHP: mono-(2-carboxymethylhexyl) phthalate, MEP: mono-ethyl phthalate, MECPP: mono-(2-ethyl-5-carboxypentyl) phthalate; MEHP: mono-ethylhexyl phthalate; MEHHP: mono-(2-ethyl-5-hydroxyhexyl) phthalate; MEOHP: mono-(2-ethyl-5-oxo-hexyl) phthalate; MMP: mono-methyl phthalate; MiNP: mono-iso-nonyl phthalate; unadjusted level of each phthalate metabolite was shown in the parentheses; ND: not detectable; Detectable rate = number of urine sample with level of each phthalate metabolite above detection limit/ all analyzed urine samples.

^b^ Mann-Whitney U test; p-value for unadjusted level of each phthalate metabolite was shown in the parentheses.

![Distribution of 11 phthalate metabolites in a sample of the general Taiwanese population (N = 387) ≥7 years of age.](pone.0133782.g002){#pone.0133782.g002}

[Fig 3](#pone.0133782.g003){ref-type="fig"} showed the distribution and median levels of phthalate metabolites in our sample of the general Taiwanese population classified into four age groups. We found that J-shape curves of the exposure levels of MEOHP (P\<0.001), MECPP(P = 0.002), MnBP (P = 0.044), MiNP (P\<0.001), MBzP (P\<0.001) and MMP (P\<0.001) in our subjects were significantly varied by age regardless of gender, which indicated minors may expose to higher level of these phthalates than adults. The median level of MEP (creatinine-unadjusted) at age 18--40 years was significantly (P\<0.001) higher than the other age groups, especially for women. Besides, median levels of MnBP and MiBP in all subjects decreased along with increasing age. No significant change of MEHP in our subjects was observed regardless of age or gender. Detailed data were shown in the [S2 Table](#pone.0133782.s002){ref-type="supplementary-material"}.

![Distribution of 11 phthalate metabolites in a sample of the general Taiwanese population (N = 387) by age groups (solid line inside the box plot: median).](pone.0133782.g003){#pone.0133782.g003}

We further categorized our subjects according to five regions ([S3 Table](#pone.0133782.s003){ref-type="supplementary-material"}). We found that the median levels of MEHP, MEHHP, MEOHP, MECPP, MCMHP, MiBP, MEP, MBzP, and MMP were statistically significant (p\<0.001) varied by region. Except for the remote island region, we observed that the median levels of MEHP, MECPP, MCMHP, MnBP, MiBP and MBzP in southern Taiwan were highest among four regions. We also observed a 2-3-fold higher median level of MMP in the remote island was higher than other regions. The median levels of MiNP and MBzP in all areas were below the detection limit.

Comparison of phthalate exposure among different countries {#sec014}
----------------------------------------------------------

[Fig 4](#pone.0133782.g004){ref-type="fig"} showed a comparison of phthalate metabolite levels in the general population between Taiwan, Canada \[[@pone.0133782.ref020]\], and the United States \[[@pone.0133782.ref027]\]. We found that the geometric mean (GM) level of MEHP in the Taiwanese population sample was 1.6-fold higher than those in the NHANES 10--11. The GM levels of secondary MEHP metabolites and MnBP in this study were comparable to those reported in the CHMS 07--08 and NHANES 10--11. The exposure levels of MEP and MBzP were approximately 5--7 times lower than those in CHMS 07--08 and NHANES 10--11.

![Comparison of urinary levels of seven phthalate metabolites in a general population sample of Taiwanese (≧7 years), Americans (\>6 years) and Canadians (18--49 years).](pone.0133782.g004){#pone.0133782.g004}

Discussion {#sec015}
==========

This is the first study systematically evaluating phthalate exposure in a sample of the general Taiwanese population. We found a significant difference in phthalate exposure according to age and gender. Minors (≧7\~\<18 years old) and elders (≧ 65 years old) tended to have exposure to higher levels of most phthalates, such as DEHP, DnBP, BBzP and DMP. Women (≧18 years old) were exposed to higher levels of DEHP, DBP (in particular DnBP) and DEP than men (≧18 years old) in Taiwan. Minors had significantly higher urinary levels of MEHHP, MEOHP, MECPP, MnBP and MiBP than the adult population, especially for boys.

High detectable rates (\>70%) of MEHP, MEOHP, MEHHP, MECPP, MnBP, MiBP, MEP and MMP were observed in this sample of the general Taiwanese population. Due to the short-half-lives of most phthalates, DEHP, DnBP, DiBP, DEP, and DMP are frequently present in the daily life of the general Taiwanese population. Over 73% of participating adults and minors frequently used food preservation film and plastic bag for food storage ([S4 Table](#pone.0133782.s004){ref-type="supplementary-material"}). About 73% and 43% of minors and adults, respectively, used body wash every day, whereas less than 2% of all participants frequently used perfume and nail polish; these results were not consistent with other studies \[[@pone.0133782.ref028]--[@pone.0133782.ref029]\]. Around 42% and 13% of minors and adults, respectively, took at least one medicine constantly during the past one month. About 25% of participants reported using pesticides at home. Plastic products related to food preservation, body wash, medicine, and pesticide usage were potential sources of different phthalates exposure in the general Taiwanese population.

A low detection rate of MiNP (11.1%) and MBzP (22.4%) in Taiwanese was observed regardless of different age groups and gender. Although DINP is a substitute for DEHP in plastics, DINP is not widely used for plastics related to products used daily in Taiwan or other Asian countries. Besides, MiNP is not the major DINP metabolite as it is converted into secondary metabolites \[[@pone.0133782.ref030]\]. Thus, the low MiNP detection rate does not imply low DINP exposure in the general Taiwanese population. It is also important to note that new plastic phthalate substitutes have been developed; their use may increase rapidly in the near future \[[@pone.0133782.ref031]\]. Monitoring secondary metabolites of DINP is worthy of further investigation in studies of Asian countries. BBzP is primarily used in PVC-based floor materials, which are not used as much for Taiwanese home decoration as in previous years. Due to MBzP being a major metabolite of BBzP, low detection of MBzP suggests low-exposure levels of BBzP in the general Taiwanese population.

We analyzed the difference of creatinine levels in our subjects by age and gender ([S5 Table](#pone.0133782.s005){ref-type="supplementary-material"}). We found that male subjects had a significantly higher median level of creatinine than females (102.4 vs. 71 mg/dl, p\<0.001) regardless of age difference. We further excluded 24 subjects with creatinine\<30 or ≧300 mg/dl for further analysis, and the results were consistent. Our study revealed that we may partially diminish the difference of phthalate exposure between males and females when using a creatinine-adjustment-based method for comparison. However, we found a significantly high correlation (R = 0.83\~0.96, P\<0.001, [S6 Table](#pone.0133782.s006){ref-type="supplementary-material"}) between creatinine-adjusted and unadjusted concentrations of each phthalate metabolites using Pearson correlation analysis. Hence, in order to adjust for individual urinary excretion rate, we primarily presented our data in a creatinine-based level.

We found that urinary levels of DEHP metabolites in minor Taiwanese boys were significantly higher than those of most adult age groups. For minors, the behaviors of hand-to-mouth exposure and use of drinking containers are the likely causes of major phthalate exposure \[[@pone.0133782.ref032]\]. DEHP is of great concern in boys due to its antiandrogenic effects \[[@pone.0133782.ref033]\]; hence, intervention strategies for reducing phthalate exposure in boys warrant further investigation. Besides, we observed that urinary MECPP and ΣDEHP metabolites levels in elderly Taiwanese women (≧65 years) were higher than in any other age group. Taiwanese elderly women use food preservation films to save leftover food heated in a microwave oven; some food preservation films are made with PVC, which may increase DEHP concentration in meals \[[@pone.0133782.ref034]\]. Another possibility is that increased phthalate levels may correlate with increased amounts of cosmetic, perfume, and personal care product usage \[[@pone.0133782.ref028]--[@pone.0133782.ref029]\] in women. Only 45% of female adults frequently used lotion and body wash every day, whereas less than 5% of them used perfume and nail polish frequently ([S4 Table](#pone.0133782.s004){ref-type="supplementary-material"}). We suggested that food preservation and personal care products are possible sources of DEHP exposure in elderly Taiwanese women.

One study reported that GM levels of urinary MEHP, MEHHP, MEOHP, MEP, MBP were around 9.87, 50.9, 24.1, 19.8 and 55.9 μg/g creatinine, respectively, in adult Taiwanese during 2005--08 \[[@pone.0133782.ref035]\], two times higher than those in the current study. However, no information was available about potential phthalate exposure sources in the Taiwanese study from 2005--08. Another study also reported median level of urinary MEHP was 29.8 μg/g creatinine in 225 school children of Taipei city during 2009--10, four times higher than those in the current study \[[@pone.0133782.ref036]\]. Our sample of the general Taiwanese population provided some evidence of decreasing DEHP and DBP levels after enacted restrictions and regulations. In adult Taiwanese women, the median levels of most phthalate metabolites in age groups between 18 to 65 years were higher than those in men. For reproductive age women (18--40 years), some studies reported DEHP and DBP exposure in pregnant women may alter human hormones \[[@pone.0133782.ref037]--[@pone.0133782.ref038]\], fetal and child development \[[@pone.0133782.ref039]--[@pone.0133782.ref040]\], and pregnancy losses \[[@pone.0133782.ref041]\], endometriosis \[[@pone.0133782.ref042]\] or leiomyoma \[[@pone.0133782.ref043]--[@pone.0133782.ref044]\]. Although limited evidence showed that exposure levels of most phthalate metabolites significantly decreased after enacted restrictions and regulation \[[@pone.0133782.ref010]\], DEHP exposure levels in reproductive-aged Taiwanese women remain higher than those reported from other countries, warranting further investigation.

We found that both children and adolescents are exposed to higher levels of phthalates, a finding consistent with other studies \[[@pone.0133782.ref020], [@pone.0133782.ref023], [@pone.0133782.ref027], [@pone.0133782.ref043]--[@pone.0133782.ref044]\]. The Canadian study reported children had significantly higher urinary concentrations of metabolites of DEHP, DnBP and BBzP than adolescents and adults \[[@pone.0133782.ref020]\]; similar results were also observed in German and NHANES studies \[[@pone.0133782.ref027],[@pone.0133782.ref044]\]. Increasing numbers of studies have reported endocrine, immunologic, and neurological effects of both prenatal and postnatal phthalates exposure in young children \[[@pone.0133782.ref011]--[@pone.0133782.ref012], [@pone.0133782.ref016]--[@pone.0133782.ref017], [@pone.0133782.ref040], [@pone.0133782.ref045]\]. Hence, regulating human biomonitoring value and intervention strategies of consumer behavior \[[@pone.0133782.ref032], [@pone.0133782.ref046]\] were necessary to reduce phthalate exposure in children.

Some studies revealed good correlations with primary and secondary DEHP metabolites in US and German populations \[[@pone.0133782.ref030], [@pone.0133782.ref044]\]. In adults, we observed a significantly low correlation between MEHP and three secondary DEHP metabolites ([S6 Table](#pone.0133782.s006){ref-type="supplementary-material"}), whereas we found moderate correlation between MEHHP and MECPP (R = 0.562, *P*\<0.001) as well as MEOHP and MCMHP (R = 0.509, *P*\<0.001). Our data showed a high correlation between MEHHP and ΣDEHP metabolites (R = 0.802, *P*\<0.001), which indicated a good surrogate exposure index of DEHP in the Taiwanese population. In minors, we found a high correlation among MEOHP (R = 0.802, *P*\<0.001), MEHHP (R = 0.782, *P*\<0.001), MECPP, and ΣDEHP metabolites ([S6 Table](#pone.0133782.s006){ref-type="supplementary-material"}). Although metabolic abilities may differentiate between age groups, we suggested MEHHP could be a good biomarker of DEHP in the general Taiwanese population.

Our current study demonstrates several strengths. First, our study was a nationwide sample of subjects, including children ≥7 years old. Second, we also collected relevant factors from our participants through interview questionnaires, allowing further analysis of potential sources of phthalate exposure. Third, we determined the internal exposure in the general population which supplied a basis for estimating phthalate-related health risks. Our data provided reference values of phthalates in the Taiwanese population.

Some limitations of our study should be noticed in relation to data interpretation. First, this is a cross-sectional study with one-time measurements. The distribution of individual phthalate exposure can vary, and therefore further study is needed for temporal assessment over time. Second, we did not have sufficient evidence to link decreased phthalate exposure to this episodes. But, enacted restrictions and regulations on phthalates can possibly decrease phthalate exposure levels from many products in the general population.

We concluded that exposure levels of phthalates varied by age and gender, and were possibly affected by different lifestyles. Enacted restrictions and regulations could effectively reduce phthalate exposure in the general population; however, continuous biomonitoring surveillance is necessary to detect the long-term level variation. Although the DEHP exposure profile dramatically dropped after strict regulation, young boys and women in Taiwan were still exposed to higher levels of certain phthalates. These related health influences, such as reproductive development, are worthy of further investigation.
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